title: Urinary apo(a) discriminates coronary artery disease patients from controls.
abstract: Increased plasma lipoprotein (a) (Lp(a)) levels are associated with premature cardiovascular diseases and stroke. Since Lp(a) immune reactivity is found in urine we compared urinary apolipoprotein (a) (apo(a)) with plasma Lp(a) levels in 116 patients suffering from angiographically proven coronary artery diseases with that of 109 controls. Urinary apo(a) investigated by immuno blotting, revealed a distinct apo(a) fragmentation pattern with molecular weights between 50 and 160 kDa. Apolipoprotein B however was not secreted into urine. Lp(a) and apo(a) were measured by a fluorescence immuno assay. Within single individuals, urinary apo(a) levels correlated significantly with creatinine (Rho, 0.98; P < 0.0005). Medians and 25/75 percentiles of urinary apo(a) in coronary artery disease (CAD) patients were 5.70, 3.25 and 10.35 microg/dl and in controls 2.64, 1.43 and 3.50 microg/dl respectively. At cut-off levels of 30 mg/dl for plasma Lp(a) and 10 microg/dl of urinary apo(a) respectively, both paramenters showed comparable sensitivities (33.8% vs. 26.7%), yet the specificity (76.1% vs. 91.7%) and the positive predictive value (60.0% vs.76.4%) of urinary apo(a) were much higher. In receiver-operating characteristic plots, urinary apo(a) was much more sensitive at high specificities i.e. greater than 60% as compared to Lp(a). Urinary secretion of apo(a) fragments normalized to creatinine is stable in a given individual and significantly associated with coronary artery disease.
authors.affiliation: Department of Cardiology, University Hospital of Vienna, Austria. kkostner@mail.kard.akh-wien.ac.at
authors.forename: K M
authors.initials: KM
authors.lastname: Kostner
authors.forename: K
authors.initials: K
authors.lastname: Huber
authors.forename: T
authors.initials: T
authors.lastname: Stefenelli
authors.forename: H
authors.initials: H
authors.lastname: Rinner
authors.forename: G
authors.initials: G
authors.lastname: Maurer
mesh_terms: D001054:Apolipoproteins A / Q000097:blood / Q000652:urine*; D015153:Blotting, Western; D017023:Coronary Angiography; D003327:Coronary Disease / Q000097:blood / Q000000981:diagnostic imaging / Q000652:urine*; D003404:Creatinine / Q000097:blood / Q000652:urine; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006801:Humans; D007118:Immunoassay; D017270:Lipoprotein(a) / Q000097:blood / Q000652:urine; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012307:Risk Factors
chemical_list: D001054:Apolipoproteins A; D017270:Lipoprotein(a); D003404:Creatinine